TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT04647240: MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers

Sponsor: Merakris Therapeutics · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 80 pts

Competing Trials Overlap

9 Active Trials

Excess Burn Exposure

$1,626,800

Rescue Site Savings

+$1,062,400

Unlock Full NCT04647240 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04647240 Rescue Dossier →